Jesus Lovera, MD, MsPH, Curriculum Vitae
Place of Birth
Bogota, Colombia
Work Address
LSUHN Baptist Memorial/ Uptown Suite 400 2820 Napoleon Ave New Orleans, LA
Education
1991-97 Pontificia Universidad Javeriana Bogotá, Colombia: MD 2001-04 Tulane University School of Public Health, New Orleans, LA: MsPH Biostatistics
Post Doctoral Training
1998-99 Ochsner Foundation, New Orleans, LA: Internal Medicine Internship 1999-02 Tulane University, New Orleans, LA: Neurology 2003-05 Oregon Health and Science University and VA MS Center of Excellence-West, Portland, OR: Multiple Sclerosis/ Neuroimmunology
Research Fellowships
2005-06 VA MS Center of Excellence-West and San Francisco VA, San Francisco, CA: Stress in Multiple Sclerosis
Licensure and Board Certification
1998 Louisiana Medical License (#024307) 2004 American Board of Psychiatry and Neurology
Academic and Administrative Appointments
2003-06 Instructor in Neurology Oregon Health & Science University 2007-08 Assistant Professor in Neurology Oregon Health & Science University 2008- Assistant Professor in Neurology Louisiana State University
Hospital Appointments
Medical Center of Louisiana, New Orleans Touro Hospital, New Orleans Baptist Hospital, New Orleans Kenner Regional Hospital, Kenner
Memberships, Offices and Committee Appointments
1998- American Academy of Neurology
Awards and Honors
1997 Honors for best GPA in class, Pontificia Universidad Javeriana 2000 Owl Club Award for Excellency in Teaching, Tulane University
Research Interests
Neuroprotective treatments for MS Advanced imaging techniques in MS Complementary and alternative medicine
Bibliography
Yadav V, Marracci G, Lovera J, Woodward W, Bogardus K, Marquardt W, Shinto L, Morris C, Bourdette D. Lipoic Acid in Multiple Sclerosis: A Pilot Study. Multiple Sclerosis. 2005; 11(2):159-65. Bourdette DN, Edmonds E, Smith C, Bowen J, Guttmann C, Nagy Z, MD; Simon J, Whitham R, Lovera J, Yadav V, Mass M, Bartholomew R, Theofan G, Milano J, Offner H, Vandenbark AA. Boosting Regulatory T cells in Multiple Sclerosis: Immunogenicity and Safety of Tripeptide BV5S2, BV6S5 & BV13S1 CDR2 Vaccine in Incomplete Freund?s Adjuvant. Multiple Sclerosis. 2005; 11(5):552-61. Lovera J, Oken B, Smoot K, Bogardus K, Frank R, Wild K, Bagert B, Whitham R, Bourdette D. Self-Perception of Cognitive Dysfunction Reflects Depression More Than Neurocognitive Abnormalities: Correlations of the Perceived Deficits Questionnaire of the Multiple Sclerosis Quality of Life Inventory with Beck?s Depression Inventory and Neuropsychological Tests. Journal of Rehabilitation Research and Development. 2006; 43(1):73-82. Oken B, Flegal K, Zajdel D, Kishiyama S, Lovera J, Bagert B, Bourdette D. Cognition and Fatigue in Multiple Sclerosis: Under-Recognized Effects of CNS-Active Medications. Journal of Rehabilitation Research and Development. 2006; 43(1):83-90. Lovera J, Bagert B, Smoot K, Morris CD, Frank R, Bogardus K, Wild K, Oken B, Whitham R, Bourdette D. Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial. Multiple Sclerosis 2007; 13(3):376-85 Vandenbark AA, Culbertson NE, Bartholomew RM, Huan J, Agotsch M, LaTocha D, Yadav V, Mass M, Whitham R, Lovera J, Milano J, Theofan G, Chou YK, Offner H, Bourdette DN. Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis. Immunology 2008; 123(1):66-78. Epub 2007 Oct 16.